Financial Metric Page

Immunome Inc.: Operating Margin

Latest period: Q4 2025. Period end: 31 Dec 2025. Units: %. Frequency: quarterly and annual.

The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.

What This Metric Tells You

  • Shows the reported level of operating margin over 31 Dec 2023 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 12 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Global Warming Solutions, Inc. (["gwso"]) 99905400% Quarter - 30 Sep 2022 Open Global Warming Solutions, Inc. Operating Margin
2 NAMI Corp. ([]) 1080289% Quarter - 31 Mar 2021 Open NAMI Corp. Operating Margin
3 PharmaCyte Biotech, Inc. (["pmcb"]) 396584% Quarter - 31 Jan 2014 Open PharmaCyte Biotech, Inc. Operating Margin
4 ALR Technologies SG Ltd. (["alrtf"]) 180380% Year - 31 Dec 2022 Open ALR Technologies SG Ltd. Operating Margin
5 MUSTANG BIO, INC. (["mbio"]) 83624% Quarter - 30 Sep 2019 Open MUSTANG BIO, INC. Operating Margin
6 DOMINION ENERGY SOUTH CAROLINA, INC. ([]) 63100% Quarter - 31 Dec 2020 Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin

Metric Details

Metric
Operating Margin (OperatingMargin)
Taxonomy
ratio
Units tracked
%
Frequency coverage
quarterly and annual
History range
31 Dec 2023 - 31 Dec 2025
Facts on this page
12
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Immunome Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -3229% +154% +4.5% 01 Oct 2025 31 Dec 2025
Q3 2025 -2420% +714% +23% 01 Jul 2025 30 Sep 2025
Q2 2025 -1784% +734% +29% 01 Apr 2025 30 Jun 2025
Q1 2025 -1994% -123% -6.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -3382% -2601% -333% 01 Oct 2024 31 Dec 2024
Q3 2024 -3134% 01 Jul 2024 30 Sep 2024
Q2 2024 -2518% 01 Apr 2024 30 Jun 2024
Q1 2024 -1871% 01 Jan 2024 31 Mar 2024
Q4 2023 -781% 01 Oct 2023 31 Dec 2023

Immunome Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -3229% +154% +4.5% 01 Jan 2025 31 Dec 2025
2024 -3382% -2601% -333% 01 Jan 2024 31 Dec 2024
2023 -781% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.